| 发明名称 |
Indolobenzazepine HCV NS5B inhibitors |
| 摘要 |
The invention encompasses compounds and salts of Formulas I, II, III, and IV as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
|
| 申请公布号 |
US7473688(B2) |
申请公布日期 |
2009.01.06 |
| 申请号 |
US20060516435 |
申请日期 |
2006.09.06 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
BERGSTROM CARL P.;BENDER JOHN A.;GENTLES ROBERT G.;HEWAWASAM PIYASENA;HUDYMA THOMAS W.;KADOW JOHN F.;MARTIN SCOTT W.;REGUEIRO-REN ALICIA;YEUNG KAP-SUN;TU YONG;GRANT-YOUNG KATHARINE A.;ZHENG XIAOFAN |
| 分类号 |
A61K31/55;A61P31/00;C07D223/14 |
主分类号 |
A61K31/55 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
